• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-A12B filed by Senseonics Holdings Inc.

    11/14/25 7:01:18 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials
    Get the next $SENS alert in real time by email
    8-A12B 1 tm2531121d2_8a12b.htm FORM 8-A12B

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

     

    FORM 8-A

     

     

     

    FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

    PURSUANT TO SECTION 12(b) OR (g) OF

    THE SECURITIES EXCHANGE ACT OF 1934

     

     

     

    SENSEONICS HOLDINGS, INC.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware 47-1210911
    (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)

     

    20451 Seneca Meadows Parkway
    Germantown, MD
    20876-7005
    (Address of principal executive offices) (Zip Code)

     

    Securities to be registered pursuant to Section 12(b) of the Act:

     

    Title of each class
    to be so registered
      Name of exchange on which
    each class is to be registered
    Common Stock, $0.001 par value per share   The Nasdaq Stock Market LLC

     

     

      

    If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. x

     

    If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ¨

     

    If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ¨

     

    Securities Act registration statement file number to which this form relates:

    N/A

     

    Securities to be registered pursuant to Section 12(g) of the Act:

    None

    (Title of class)

     

     

     

     

     

    EXPLANATORY NOTE

     

    Senseonics Holdings, Inc., a Delaware corporation (the “Registrant”) is filing this registration statement on Form 8-A in connection with the transfer of the listing of its common stock, par value $0.001 per share from the NYSE American to The Nasdaq Stock Market LLC.

     

    Item 1. Description of Registrant’s Securities to be Registered.

     

    The following summary of the terms of Registrant’s capital stock is based on our amended and restated certificate of incorporation (the “A&R Certificate of Incorporation”), as amended to date by Certificates of Amendment to Amended and Restated Certificate of Incorporation (the “Certificates of Amendment” and together with the A&R Certificate of Incorporation, the “Certificate of Incorporation”), and our amended and restated bylaws, as amended (the “Restated Bylaws”). The summary is not complete and is qualified by reference to the A&R Certificate of Incorporation, filed as Exhibit 3.1 to our Current Report on Form 8-K filed on March 23, 2016, the Certificates of Amendment, filed as Exhibit 3.3 to our Current Report on Form 8-K filed on August 8, 2018, Exhibit 3.1 to our Current Report on Form 8-K filed on May 22, 2024 and Exhibit 3.1 to our Current Report on Form 8-K filed on October 16, 2025, and the Restated Bylaws, filed as Exhibit 3.2 to our Current Report on Form 8-K filed on March 23, 2016, and incorporated by reference herein. We encourage you to read our Certificate of Incorporation, Restated Bylaws and the applicable provisions of the Delaware General Corporation Law (the “DGCL”) for additional information.

     

    General

     

    The Certificate of Incorporation authorizes the issuance of up to 70,000,000 shares of common stock, $0.001 par value per share, and 5,000,000 shares of preferred stock, $0.001 par value per share. The Registrant’s board of directors may establish the rights and preferences of the preferred stock from time to time. As of November 12, 2025, we had 40,858,460 shares of common stock outstanding and no shares of preferred stock outstanding.

     

    Common Stock

     

    Voting

     

    Each holder of common stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders, including the election of directors. Under the Certificate of Incorporation and Restated Bylaws, common stockholders do not have cumulative voting rights. Because of this, the holders of a majority of the shares of common stock entitled to vote in any election of directors can elect all of the directors standing for election, if they should so choose.

     

    Dividends

     

    Holders of common stock are entitled to receive ratably those dividends, if any, as may be declared from time to time by the board of directors out of legally available funds, subject to dividend preferences of any outstanding shares of preferred stock.

     

    Liquidation

     

    In the event of the Registrant’s liquidation, dissolution or winding up, holders of common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders, subject to liquidation preferences of any outstanding shares of preferred stock.

     

     1 

     

     

    Rights, Preferences, and Privileges

     

    Holders of common stock have no preemptive, conversion or subscription rights and there are no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that the Registrant may designate in the future.

     

    Fully Paid and Nonassessable

     

    All of our outstanding shares of common stock are fully paid and nonassessable.

     

    Preferred Stock

     

    Pursuant to the Certificate of Incorporation, our board of directors has the authority, without further action by the stockholders (unless such stockholder action is required by applicable law or stock exchange listing rules), to designate and issue up to 5,000,000 shares of preferred stock in one or more series, to establish from time to time the number of shares to be included in each such series, to fix the designations, powers, preferences, privileges and relative participating, optional or special rights and the qualifications, limitations or restrictions thereof. We have designated 30,000 shares of preferred stock as Series A Convertible Preferred Stock and 12,000 shares of preferred stock as Series B Convertible Preferred Stock. As of the date hereof, no shares of preferred stock are outstanding.

     

    Item 2. Exhibits.

     

    Under the “Instructions as to Exhibits” with respect to Form 8-A, no exhibits are required to be filed with this registration statement because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

     

     2 

     

     

    SIGNATURE

     

    Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

     

      SENSEONICS HOLDINGS, INC.
         
    Date: November 14, 2025 By: /s/ Rick Sullivan
        Rick Sullivan
        Chief Financial Officer

     

     3 

     

    Get the next $SENS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SENS

    DatePrice TargetRatingAnalyst
    10/21/2025$9.00Hold
    Stifel
    8/27/2025$1.50Overweight
    Barclays
    7/15/2025$1.25Buy
    TD Cowen
    6/2/2025$1.10Buy
    H.C. Wainwright
    4/10/2025$2.00Outperform
    Mizuho
    7/19/2023$0.50Underperform
    Jefferies
    8/19/2021$6.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $SENS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stifel resumed coverage on Senseonics with a new price target

    Stifel resumed coverage of Senseonics with a rating of Hold and set a new price target of $9.00

    10/21/25 7:22:14 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Barclays initiated coverage on Senseonics with a new price target

    Barclays initiated coverage of Senseonics with a rating of Overweight and set a new price target of $1.50

    8/27/25 8:26:33 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    TD Cowen initiated coverage on Senseonics with a new price target

    TD Cowen initiated coverage of Senseonics with a rating of Buy and set a new price target of $1.25

    7/15/25 8:44:36 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Kaufman Francine covered exercise/tax liability with 4,605 shares, decreasing direct ownership by 4% to 123,948 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    11/18/25 7:00:12 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Chief Financial Officer Sullivan Frederick T. covered exercise/tax liability with 6,402 shares, decreasing direct ownership by 4% to 150,626 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    11/18/25 7:00:17 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    GC & Corp. Development Advisor Horton Kenneth L covered exercise/tax liability with 5,997 shares, decreasing direct ownership by 4% to 144,434 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    11/18/25 7:00:08 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference

    GERMANTOWN, Md., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Stifel 2025 Healthcare Conference, being held in New York, NY. 2025 Stifel Healthcare Conference Format: Fireside chat and one-on-one meetingsDate: Wednesday, November 12, 2025Time: 4:40 pm ETWebcast: Click here Interested parties may access a live and recorded webcast of the presentation on the "Investor Relations" section of the company's website at www.senseonics.com. About Se

    11/10/25 8:05:00 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Senseonics Announces Transfer to Nasdaq Stock Exchange

    GERMANTOWN, Md., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, has announced that as a decision in the best interest of the Company and its stockholders, it will transfer the listing of its common stock from the NYSE American to the Nasdaq Global Select Market ("Nasdaq"), effective after the market closes on November 14, 2025. The Company's stock is expected to begin trading on Nasdaq under the existing ticker symbol "SENS" on November 17, 2025. About Senseonics Senseonics Holdings, Inc. ("Sense

    11/10/25 8:00:00 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Senseonics Holdings, Inc. Reports Third Quarter Financial Results

    Generated Q3 revenue of $8.1 million, representing year-over-year growth of 90% Achieved a 160% increase in U.S. new patient starts over prior year Planning for the transition of CGM commercial responsibility from Ascensia Diabetes Care back to Senseonics GERMANTOWN, Md., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the third quarter ended September 30, 2025. Recent Highlights & Accomplishments: Generated revenue of $8.1 million in the third quarter of 2

    11/5/25 4:05:00 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Steven Edelman bought $65,500 worth of shares (10,000 units at $6.55), increasing direct ownership by 15% to 74,708 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    11/13/25 4:48:53 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Chief Financial Officer Sullivan Frederick T. bought $31,840 worth of shares (5,415 units at $5.88), increasing direct ownership by 4% to 157,028 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    11/10/25 7:40:12 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Director Roeder Douglas A bought $87,450 worth of shares (15,000 units at $5.83), increasing direct ownership by 18% to 99,727 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    11/10/25 7:40:13 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    SEC Filings

    View All

    SEC Form CERT filed by Senseonics Holdings Inc.

    CERT - Senseonics Holdings, Inc. (0001616543) (Filer)

    11/14/25 12:32:49 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    SEC Form 8-A12B filed by Senseonics Holdings Inc.

    8-A12B - Senseonics Holdings, Inc. (0001616543) (Filer)

    11/14/25 7:01:18 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    SEC Form 25 filed by Senseonics Holdings Inc.

    25 - Senseonics Holdings, Inc. (0001616543) (Filer)

    11/14/25 7:00:15 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    Financials

    Live finance-specific insights

    View All

    Senseonics Holdings, Inc. Reports Third Quarter Financial Results

    Generated Q3 revenue of $8.1 million, representing year-over-year growth of 90% Achieved a 160% increase in U.S. new patient starts over prior year Planning for the transition of CGM commercial responsibility from Ascensia Diabetes Care back to Senseonics GERMANTOWN, Md., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the third quarter ended September 30, 2025. Recent Highlights & Accomplishments: Generated revenue of $8.1 million in the third quarter of 2

    11/5/25 4:05:00 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time

    GERMANTOWN, Md., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its third quarter 2025 financial results after market close on Wednesday, November 5, 2025. Management will hold a conference call to review the Company's third quarter 2025 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by na

    10/22/25 4:05:00 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

    CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million with Hercules Capital to fund commercial organization Conference Call scheduled for September 4, 2025 at 8:00 A.M. Eastern Time GERMANTOWN, Md., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced a mutually executed Memorandum of Understanding to transition all commercialization and distributio

    9/3/25 5:17:09 PM ET
    $HTGC
    $SENS
    Investment Managers
    Finance
    Industrial Machinery/Components
    Industrials

    $SENS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Senseonics Holdings Inc. (Amendment)

    SC 13G/A - Senseonics Holdings, Inc. (0001616543) (Subject)

    2/13/24 5:13:59 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Senseonics Holdings Inc. (Amendment)

    SC 13G/A - Senseonics Holdings, Inc. (0001616543) (Subject)

    7/7/23 4:35:55 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G filed by Senseonics Holdings Inc.

    SC 13G - Senseonics Holdings, Inc. (0001616543) (Subject)

    4/10/23 5:10:45 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials